The Latin America, Middle East and Africa DNases, Ligases, And RNA Polymerases Market would witness market growth of 12.1% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA DNases, Ligases, And RNA Polymerases Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $30.3 Million by 2031. The Argentina market is showcasing a CAGR of 13% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 11.7% during (2024 - 2031).
Clinical laboratories adopt DNases, Ligases, and RNA polymerases for molecular diagnostics, genetic testing, and disease detection. These enzymes play a vital role in PCR-based assays for detecting genetic mutations, infectious agents, and cancer biomarkers. Diagnostic companies utilize DNases, Ligases, and RNA Polymerases to develop molecular tests for diagnosing genetic disorders, infectious diseases, and cancer, providing valuable information for patient management and treatment decisions.
In addition, forensic laboratories employ DNases, Ligases, and RNA Polymerases in DNA analysis for forensic identification, paternity testing, and criminal investigations. These enzymes extract, amplify, and analyze DNA evidence from crime scenes, enabling forensic scientists to identify individuals, establish familial relationships, and provide evidence for legal proceedings. DNases, Ligases, and RNA Polymerases are critical tools in forensic DNA profiling and crime scene analysis.
Adopting GMOs in these staple crops fuels the demand for enzymes involved in their genetic modification and evaluation. Soybean adoption rates were 98%, maize adoption rates were 88%, and cotton adoption rates were 80%. The average yields for grains and oilseeds increased by 70 percent during the past 15 years, with the continued use of biotechnology seeds being a major contributor to this yield growth. Therefore, the market is growing due to the increasing application of biotechnology in agriculture and the rise of the pharmaceutical industry in the region.
Based on DNases Application, the market is segmented into Biopharmaceutical Processing and Others. Based on Ligases Application, the market is segmented into Oligonucleotide Synthesis and Others. Based on RNA Polymerases Application, the market is segmented into mRNA Production and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA DNases, Ligases, And RNA Polymerases Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $30.3 Million by 2031. The Argentina market is showcasing a CAGR of 13% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 11.7% during (2024 - 2031).
Clinical laboratories adopt DNases, Ligases, and RNA polymerases for molecular diagnostics, genetic testing, and disease detection. These enzymes play a vital role in PCR-based assays for detecting genetic mutations, infectious agents, and cancer biomarkers. Diagnostic companies utilize DNases, Ligases, and RNA Polymerases to develop molecular tests for diagnosing genetic disorders, infectious diseases, and cancer, providing valuable information for patient management and treatment decisions.
In addition, forensic laboratories employ DNases, Ligases, and RNA Polymerases in DNA analysis for forensic identification, paternity testing, and criminal investigations. These enzymes extract, amplify, and analyze DNA evidence from crime scenes, enabling forensic scientists to identify individuals, establish familial relationships, and provide evidence for legal proceedings. DNases, Ligases, and RNA Polymerases are critical tools in forensic DNA profiling and crime scene analysis.
Adopting GMOs in these staple crops fuels the demand for enzymes involved in their genetic modification and evaluation. Soybean adoption rates were 98%, maize adoption rates were 88%, and cotton adoption rates were 80%. The average yields for grains and oilseeds increased by 70 percent during the past 15 years, with the continued use of biotechnology seeds being a major contributor to this yield growth. Therefore, the market is growing due to the increasing application of biotechnology in agriculture and the rise of the pharmaceutical industry in the region.
Based on DNases Application, the market is segmented into Biopharmaceutical Processing and Others. Based on Ligases Application, the market is segmented into Oligonucleotide Synthesis and Others. Based on RNA Polymerases Application, the market is segmented into mRNA Production and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Promega Corporation
- Raybiotech Life, Inc.
- Qiagen N.V
- Abnova Corporation
- Takara Bio Inc. (Takara Holdings Inc.)
- BPS Bioscience, Inc.
- New England Biolabs, Inc.
Market Report Segmentation
By DNases Application- Biopharmaceutical Processing
- Others
- Oligonucleotide Synthesis
- Others
- mRNA Production
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA DNases, Ligases, And RNA Polymerases Market by DNases Application
Chapter 6. LAMEA DNases, Ligases, And RNA Polymerases Market by Ligases Application
Chapter 7. LAMEA DNases, Ligases, And RNA Polymerases Market by RNA Polymerases Application
Chapter 8. LAMEA DNases, Ligases, And RNA Polymerases Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Promega Corporation
- Raybiotech Life, Inc.
- Qiagen N.V
- Abnova Corporation
- Takara Bio Inc. (Takara Holdings Inc.)
- BPS Bioscience, Inc.
- New England Biolabs, Inc.
Methodology
LOADING...
